Pure Global

SOPHIA GENETICS S.A - Authorized Company ProfileSOPHIA GENETICS S.A

Explore comprehensive authorized company profile for SOPHIA GENETICS S.A through Pure Global AI's free Colombia medical device database. This company manufactures 79 medical devices registered with INVIMA across 3 risk classes. Their registration history spans from Apr 17, 2028 to Mar 18, 2034.

This page provides detailed insights including recent registrations, risk class distribution (I: 62, Unspecified: 16, II: 1), and complete regulatory information from the official Colombia INVIMA medical device database with bilingual Spanish/English support. Pure Global AI offers free access to Colombia's complete medical device registry.

Free Authorized Company Profile
Powered by Pure Global AI
79 Devices
3 Risk Classes
SOPHIA GENETICS S.A
SOPHIA GENETICS S.A
Authorized Company
79
Total Devices
3
Risk Classes
2028
Earliest
2034
Latest
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
Recent Registrations
Latest 20 INVIMA device registrations

4. CS - SOPHIA DDM™ CUSTOM SOLUTION ROS 45 GENES - ILL -R - SR - Y07 – 32RX

4. CS - SOPHIA DDM™ CUSTOM SOLUTION ROS 45 GENES - ILL -R - SR - Y07 – 32RX

7d44e61b4af1af35f3d7e44ebd82c43c

I
Mar 18, 2034

3. CS - SOPHIA DDM™ CUSTOM SOLUTION CCLL_A_V3 23 GENES - ILL - R – SM – Y10 - 16RX

3. CS - SOPHIA DDM™ CUSTOM SOLUTION CCLL_A_V3 23 GENES - ILL - R – SM – Y10 - 16RX

92ed89c1026ff94f0dbdb08bbd12a363

I
Mar 18, 2034

5. BS - SOPHIA DDM™ HOMOLOGOUS RECOMBINATION SOLUTION V1 - ILL - R – SM – Y10 – 16RX

5. BS - SOPHIA DDM™ HOMOLOGOUS RECOMBINATION SOLUTION V1 - ILL - R – SM – Y10 – 16RX

f7a941d9a2f216476dd08e6af47d81d2

I
Mar 18, 2034

1. BS - SOPHIA DDM™ MYELOID PLUS SOLUTION V1 - ILL - RSM - Y10 - 16RX

1. BS - SOPHIA DDM™ MYELOID PLUS SOLUTION V1 - ILL - RSM - Y10 - 16RX

2a02a566340e4d107b46d656256daf45

Mar 18, 2034

2. CS - SOPHIA DDM™ CUSTOM SOLUTION CCLL_A_V3 23 GENES - ILL - R – SM – Y01 - 16RX

2. CS - SOPHIA DDM™ CUSTOM SOLUTION CCLL_A_V3 23 GENES - ILL - R – SM – Y01 - 16RX

71383e838f905efcee4e48ee31f918c2

I
Mar 18, 2034

CS - SOPHIA DDM CUSTOM SOLUTION CCOP_A_V1 478 GENES - ILL - R - GL - Y05 - 32RX

CS - SOPHIA DDM CUSTOM SOLUTION CCOP_A_V1 478 GENES - ILL - R - GL - Y05 - 32RX

069250ae50f2725256ea2014858413fb

Jan 05, 2034

8. CS - SOPHIA DDM CUSTOM SOLUTION (PHARM_B_V1) -ILL - R - GL - Y01 - 48RX

8. CS - SOPHIA DDM CUSTOM SOLUTION (PHARM_B_V1) -ILL - R - GL - Y01 - 48RX

69084404e784a6ac477cbcc682643667

I
Dec 07, 2033

5. CS - SOPHIA DDM CUSTOM SOLUTION (CCLL_A_V3) -ILL - R - SM - Y01 - 32RX

5. CS - SOPHIA DDM CUSTOM SOLUTION (CCLL_A_V3) -ILL - R - SM - Y01 - 32RX

0842fc35fea85ea9f420b4093c2a37e4

I
Dec 07, 2033

9. CS - SOPHIA DDM CUSTOM SOLUTION (PHARM_B_V1) -ILL - R - GL - Y01 - 96RX

9. CS - SOPHIA DDM CUSTOM SOLUTION (PHARM_B_V1) -ILL - R - GL - Y01 - 96RX

95f5a6e99e379a45d4b7ec02c7225e61

I
Dec 07, 2033

11. CS - SOPHIA DDM CUSTOM SOLUTION (CLYMP_B_V1) - ILL -R - SM -Y01 - 48RX

11. CS - SOPHIA DDM CUSTOM SOLUTION (CLYMP_B_V1) - ILL -R - SM -Y01 - 48RX

85b09a8454ceb9ae08a74af499f85ed3

I
Dec 07, 2033

3. CS - SOPHIA DDM CUSTOM SOLUTION (CHCS_AA) - ILL- R - GL - Y01 - 96RX

3. CS - SOPHIA DDM CUSTOM SOLUTION (CHCS_AA) - ILL- R - GL - Y01 - 96RX

66375f53783853c164de67c73d543283

I
Dec 07, 2033

4. CS - SOPHIA DDM CUSTOM SOLUTION (CCLL_A_V3) - ILL -R - SM - Y01 - 16RX

4. CS - SOPHIA DDM CUSTOM SOLUTION (CCLL_A_V3) - ILL -R - SM - Y01 - 16RX

51a100dee222896d04e75a2aba9203b2

I
Dec 07, 2033

6. CS - SOPHIA DDM CUSTOM SOLUTION (CCLL_A_V3) -ILL - R - SM - Y01 - 48RX

6. CS - SOPHIA DDM CUSTOM SOLUTION (CCLL_A_V3) -ILL - R - SM - Y01 - 48RX

1d2905560069dc2c734f56e797b47d4e

I
Dec 07, 2033

7. CS - SOPHIA DDM CUSTOM SOLUTION (PHARM_B_V1) -ILL - R - GL - Y01 - 32RX

7. CS - SOPHIA DDM CUSTOM SOLUTION (PHARM_B_V1) -ILL - R - GL - Y01 - 32RX

935fcdf4b4c59756ae7d33c466665b2e

I
Dec 07, 2033

10. CS - SOPHIA DDM CUSTOM SOLUTION (CLYMP_B_V1) -ILL - R - SM - Y01 - 32RX

10. CS - SOPHIA DDM CUSTOM SOLUTION (CLYMP_B_V1) -ILL - R - SM - Y01 - 32RX

2c511f1585294695ba6fa2b20c010fab

I
Dec 07, 2033

12. SOPHIA DDM CUSTOM SOLUTION (CCLL_A_V3) V3

12. SOPHIA DDM CUSTOM SOLUTION (CCLL_A_V3) V3

4cfaf7571ae9cc94e14f32c1a9fc17aa

I
Dec 07, 2033

2. CS - SOPHIA DDM CUSTOM SOLUTION (CHCS_AA) - ILL- R - GL - Y01 - 48RX

2. CS - SOPHIA DDM CUSTOM SOLUTION (CHCS_AA) - ILL- R - GL - Y01 - 48RX

f7f374edf7a75a1e74c4db08a7e0a128

I
Dec 07, 2033

1. CS - SOPHIA DDM CUSTOM SOLUTION (CHCS_AA) - ILL- R - GL - Y01 - 32RX

1. CS - SOPHIA DDM CUSTOM SOLUTION (CHCS_AA) - ILL- R - GL - Y01 - 32RX

ada3f17e51e5ea93652091ef632fbcc1

Dec 07, 2033

5. SOPHIA DDM™ HOMOLOGOUS RECOMBINATION DEFICIENCY SOLUTION (HRD_V1) V1

5. SOPHIA DDM™ HOMOLOGOUS RECOMBINATION DEFICIENCY SOLUTION (HRD_V1) V1

94820ed9e9be51f5ecd00d48c32282fb

I
May 03, 2033

4. SOPHIA DDM™ SOLID TUMOR PLUS SOLUTION (STS PLUS_V1) V1

4. SOPHIA DDM™ SOLID TUMOR PLUS SOLUTION (STS PLUS_V1) V1

d80e48847219d2d64effb612d54f0719

I
May 03, 2033
Risk Class Distribution
Devices by risk class
I
62
78.5% of total
Unspecified
16
20.3% of total
II
1
1.3% of total